Ibudilast (AV-411): a new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes
Journal Article
Overview
publication date
has subject area
-
Animal Diseases - Disease Models, Animal
-
Animals
-
Chemically-Induced Disorders - Opioid-Related Disorders
-
Chemically-Induced Disorders - Substance Withdrawal Syndrome
-
Drug Administration Schedule
-
Drugs, Investigational
-
Environment and Public Health - Follow-Up Studies
-
Environment and Public Health - Prospective Studies
-
Female
-
Health Care Evaluation Mechanisms - Follow-Up Studies
-
Health Care Evaluation Mechanisms - Prospective Studies
-
Health Care Evaluation Mechanisms - Treatment Outcome
-
Health Services Administration - Treatment Outcome
-
Humans
-
Investigative Techniques - Follow-Up Studies
-
Investigative Techniques - Prospective Studies
-
Male
-
Mental Disorders - Opioid-Related Disorders
-
Mental Disorders - Substance Withdrawal Syndrome
-
Models, Animal - Disease Models, Animal
-
Models, Biological - Disease Models, Animal
-
Nervous System Diseases - Neuralgia
-
Nervous System Diseases - Pain, Intractable
-
Peripheral Nervous System Diseases - Neuralgia
-
Pharmacological Phenomena - Dose-Response Relationship, Drug
-
Prognosis
-
Prognosis - Treatment Outcome
-
Pyridines
-
Rats
-
Signs and Symptoms - Neuralgia
-
Signs and Symptoms - Pain, Intractable
-
Toxicological Phenomena - Dose-Response Relationship, Drug
Full Author List
-
Ledeboer A; Hutchinson MR; Watkins LR; Johnson KW
published in
Other Profiles
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue